RISKS VERSUS BENEFITS IN ANTISCHISTOSOMAL THERAPY

Publisher Website

1 October 1969

journal article
Published by Wiley in Annals of the New York Academy of Sciences

Vol. 160 (2) , 811-820
https://doi.org/10.1111/j.1749-6632.1969.tb15902.x

Abstract

No abstract available

Keywords

This publication has 6 references indexed in Scilit:

TREATMENT OF URINARY SCHISTOSOMIASIS WITH NIRIDAZOLE (AMBILHAR) IN 576 AFRICAN SCHOOLCHILDREN
The Lancet, 1967
Clinical trial with Ambilhar in Schistosoma mansoni infections in Tanzania.
BMJ, 1966
The effect of CIBA 32,644-Ba in the treatment of 1,059 cases of vesical and intestinal schistosomiasis
Pathogens and Global Health, 1966
Selective Uptake of an Antibilharzial Nitrothiazole Compound by Schistosoma mansoni
Nature, 1966
RADIOLOGICAL CHANGES AFTER MEDICAL TREATMENT OF VESICAL SCHISTOSOMIASIS
The Lancet, 1966
Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania.
BMJ, 1966